Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Non-Current Assets (2020 - 2026)

Bioventus filings provide 6 years of Non-Current Assets readings, the most recent being $410.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 9.2% to $410.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 11.87% decrease, with the full-year FY2025 number at $410.7 million, down 9.2% from a year prior.
  • Non-Current Assets hit $410.7 million in Q4 2025 for Bioventus, down from $420.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.1 billion in Q4 2022 to a low of $356.6 million in Q3 2021.
  • Median Non-Current Assets over the past 5 years was $505.8 million (2024), compared with a mean of $605.5 million.
  • Biggest five-year swings in Non-Current Assets: soared 240.59% in 2021 and later tumbled 50.65% in 2023.
  • Bioventus' Non-Current Assets stood at $962.8 million in 2021, then grew by 14.26% to $1.1 billion in 2022, then tumbled by 50.65% to $542.9 million in 2023, then decreased by 16.68% to $452.3 million in 2024, then decreased by 9.2% to $410.7 million in 2025.
  • The last three reported values for Non-Current Assets were $410.7 million (Q4 2025), $420.7 million (Q3 2025), and $431.6 million (Q2 2025) per Business Quant data.